Compare Moody's Corporation (MCO) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moody's Corporation vs Moderna, Inc. — how do they compare? Moody's Corporation trades at $476.73 (market cap $82.52B), while Moderna, Inc. trades at $60.81 (market cap $24.18B). The key difference: Moody's Corporation is far larger — about 3.4× Moderna, Inc.'s market cap, and Moody's Corporation pays a 0.86% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MCO | MRNA | |
|---|---|---|
Market Cap | $82.52B | $24.18B |
Sector | Financials | Health |
52-Week High | $539.61 | $81.80 |
52-Week Low | $412.23 | $22.36 |
Enterprise Value | $88.54B | $20.33B |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
